Monitor for any subsequent takedown notices or warrant exercise announcements. The resale registration is a contractual obligation and does not signal new capital needs. The $14.5M potential from warrants is contingent on stock price performance.
Price Chart
Executive Summary
The SEC declared effective Entera Bio's S-3 registration statement (File No. 333-295710) on May 15, 2026, covering the resale of 19.6M ordinary shares by BVF entities from a $10M private placement. The company receives no proceeds from resales but could gain up to $14.5M from warrant exercises. This is a routine contractual step, not a new capital raise.
Key Facts
- Effectiveness date: May 15, 2026
- Registration covers 19.6M ordinary shares for resale by BVF entities
- Shares originated from a $10M private placement on April 2, 2026
- Company will not receive proceeds from resales
- Potential additional proceeds of up to $14.5M from warrant exercises
- Shelf registration (S-3) now effective; offerings can be taken down
Financial Impact
No immediate capital raised; up to $14.5M potential from warrant exercises
Risk Factors
- Resale of 19.6M shares could create overhang pressure on ENTX stock
- Warrant exercises may not occur if stock price is below exercise price
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001673 |
| Document: 9999999995-26-001673-index.html | 9999999995-26-001673 |
| Document: 9999999995-26-001673.txt | 9999999995-26-001673 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | DEF 14A | $2.77 | awaiting T+60 | — | $2.86 (+3.25%) |
Oct 6, 2026 20d ago | 8-K | $2.53 | awaiting T+60 | — | $2.86 (+13.04%) |
Aug 27, 2026 8w ago | Press Release | $3.08 | awaiting T+60 | — | $2.86 (−7.14%) |
Aug 18, 2026 9w ago | 8-K | $2.89 | awaiting T+60 | — | $2.86 (−1.04%) |
Aug 7, 2026 11w ago | Press Release | $3.04 | awaiting T+60 | — | $2.86 (−5.92%) |
Jul 29, 2026 12w ago | Press Release | $3.00 $3.02 | ▲ +0.67% | ▼ −4.06% | $2.86 (−4.67%) |
Jun 16, 2026 18w ago | Press Release | $1.18 $2.79 | ▲ +136.44% | ▲ +135.44% | $2.86 (+142.37%) |
May 28, 2026 21w ago | Press Release | $1.22 $3.23 | ▲ +164.75% | ▲ +163.02% | $2.86 (+134.43%) |
May 18, 2026 23w ago | EFFECT | $1.23 $2.80 | ▲ +127.64% | ▲ +122.79% | $2.86 (+132.52%) |
May 8, 2026 24w ago | S-3 | $1.17 $2.81 | ▲ +140.17% | ▲ +135.78% | $2.86 (+144.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers